FDG-PET, a Complementary Modality to Computed-Tomography in Radiotherapy Target Volume Delineation for Head and Neck Cancer.
Publication/Presentation Date
2-1-2012
Abstract
OBJECTIVES: The objective of the current review was to use published data to assess the role of
METHODS: Studies were identified by searching PubMed electronic databases. Both prospective and retrospective studies were included. Information regarding the role of FDG-PET for radiotherapy target volume delineation for HNC was analyzed.
RESULTS: FDG-PET is a promising tool for improving radiotherapy target volume delineation by defining a metabolically active biological target volume (BTV). The use of novel PET tracers representing properties such as hypoxia, protein synthesis and proliferation remain to be better characterized.
CONCLUSIONS: The role of FDG-PET for radiotherapy target volume delineation for patients with HNC is expanding and should be further evaluated in clinical trials.
Volume
3
Issue
1
ISSN
2155-9619
Published In/Presented At
Bar-Ad, V., Shi, W., Tuluc, M., Ohri, N., Cognetti, D., Curry, J., & Intenso, C. (2012). FDG-PET, a Complementary Modality to Computed-Tomography in Radiotherapy Target Volume Delineation for Head and Neck Cancer. Journal of nuclear medicine & radiation therapy, 3(1), 10.4172/2155-9619.1000124. https://doi.org/10.4172/2155-9619.1000124
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
24179702
Department(s)
Administration and Leadership
Document Type
Article